Panelists discuss how spinal muscular atrophy (SMA) progresses over time, affecting motor function differently in older patients vs infants, with experts noting the shift from traditional ...

Panelists discuss how the needs of older patients with spinal muscular atrophy (SMA) differ from infants, focusing on independence, education, career goals, fatigue management, and quality of life ...

In other words, it could be mistaken for a software patch. After all, the new logo has not been updated on Android and other platforms, or at least not yet. No big reveal this time. No corporate ...

Novartis is set to launch its one-off gene therapy Zolgensma for the ultra-rare muscle-wasting disease spinal muscular atrophy (SMA) in Germany at the start of July priced at 1,945,000 eu ...

There are endless options out there, and a good chunk of those products are duds. What seems great at first may quickly drop in performance and quality. We’re here to ensure you only get the ...